NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
Key findings of IMPROVE-IT trial and their possible significance for clinical practice are discussed.
Saved in:
Main Author: | S. Yu. Martsevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/123 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01) -
Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01) -
Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it?
by: N. O. Vasyukova, et al.
Published: (2019-07-01) -
Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01) -
NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)